参考文献

［1］　Ziaeian，Fonarow GC.Epidemiology and aetiology of heart failure［J］.Nat Rev Cardiol，2016，13：368-378.

［2］　Roger VL.Epidemiology of heart failure：A contemporary perspective［J］.Circ Res，2021，128：1421-1434.

［3］　Groenewegen A，Rutten FH，Mosterd A，et al.Epidemiology of heart failure［J］.Eur J Heart Fail，2020，22：1342-1356.

［4］　Zhang Y，Zhang J，Butler J，et al.Contemporary epidemiology，management，and outcomes of patients hospitalized for heart failure in China：Results from the China heart failure（China-HF）registry［J］.J Card Fail，2017，23：868-875.

［5］　Savarese G，Lund LH.Global public health burden of heart failure［J］.Card Fail Rev，2017，3：7-11.(https://www.daowen.com)

［6］　GBD 2017 Causes of Death Collaborators.Global，regional，and national age-sex-specific mortality for 282 causes of death in 195 countries and territories，1980-2017：A systematic analysis for the Global Burden of Disease Study 2017［J］.Lancet，2018，392：1736-1788.

［7］　Goonesekera S，Rudnicka-Noulin D，Isherwood A.The burden of heart failure in North America and Western Europe［J］.Future Cardiol，2021，17：637-646.

［8］　Zhang D，Tu H，Wadman MC，et al.Substrates and potential therapeutics of ventricular arrhythmias in heart failure［J］.Eur J Pharmacol，2018，833：349-356.

［9］　Imberti JF，Tosetti A，Mei DA，et al.Remote monitoring and telemedicine in heart failure：Implementation and benefits［J］.Curr Cardiol Rep，2021，23：55.

［10］　Correa A，Rochlani Y，Aronow WS.Current pharmacotherapeutic strategies for cardiac arrhythmias in heart failure［J］.Expert Opin Pharmacother，2020，21：339-352.